CRC
Clinical trials for CRC explained in plain language.
Never miss a new study
Get alerted when new CRC trials appear
Sign up with your email to follow new studies for CRC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat colon cancer: targeted combo shows promise in early trial
Disease control OngoingThis study tests a new drug called onvansertib added to standard chemotherapy and a targeted therapy for people with advanced colorectal cancer that has a specific gene change (KRAS or NRAS mutation). About 113 people who have not had prior treatment for their metastatic cancer w…
Matched conditions: CRC
Phase: PHASE2 • Sponsor: Cardiff Oncology • Aim: Disease control
Last updated May 17, 2026 02:59 UTC
-
Cancer combo trial pulled before it even started
Disease control TerminatedThis study was designed to test a new drug (NGM707) combined with an existing immunotherapy (pembrolizumab) in people with advanced solid tumors that could not be treated with surgery or radiation. The goal was to see if the combination could shrink tumors and to check for side e…
Matched conditions: CRC
Phase: PHASE2 • Sponsor: NGM Biopharmaceuticals, Inc • Aim: Disease control
Last updated May 15, 2026 11:56 UTC